Xeris Share News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rule 2.5 Announcement: Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
THIS ANNOUNCEMENT IS BEING MADE PURSUANT TO RULE 2.5 OF THE IRISH TAKEOVER RULES
FOR IMMEDIATE RELEASE
Transaction Creates Fast-Growing Biopharmaceutical Company with Two Commercial Assets and Robust Clinical Pipeline with Multiple Near-term Inflection Points
Diversifies Revenue Base with Two Rapidly Growing Brands in Xeris Gvoke® and Strongbridge s KEVEYIS® ....

New York , United States , District Of Columbia , State Of New York , Jeffreyw Sherman , Strongbridge Rsus , Andy Brimmer , Meagher Flom , Marten Steen , Joele Frank , Paulr Edick , Paul Edick , Allison Wey , Lindsay Rocco , Garheng Kong , Johnh Johnson , Strongbridge Biopharma , Wilkinson Brimmer Katcher , John Johnson , Development Pipeline , Xeris Party , Court Meeting Resolution , Registrar Of Companies , Strongbridge Us Inc , Us Food Drug Administration Orange Book , Court Meeting ,